Abstract
Cardiac fibroblasts are the most abundant cell in the mammalian heart. While they have been historically overlooked in terms of functional contributions to development and physiology, cardiac fibroblasts are now front and center. They are currently recognized as key protagonists during both normal development and cardiomyopathy disease, and work together with cardiomyocytes through paracrine, structural, and potentially electrical interactions. However, the lack of specific biomarkers and fibroblast heterogeneous nature currently convolutes the study of this dynamic cell lineage; though, efforts to advance marker analysis and lineage mapping technologies are ongoing. These tools will help elucidate the functional significance of fibroblast–cardiomyocyte interactions in vivo and delineate the dynamic nature of normal and pathological cardiac fibroblasts. Since therapeutic promise lies in understanding the interface between developmental biology and the postnatal injury response, future studies to understand the divergent roles played by cardiac fibroblasts both in utero and following cardiac insult are essential.
Similar content being viewed by others
References
Snider, P., Standley, K. N., Wang, J., Azhar, M., Doetschman, T., & Conway, S. J. (2009). Origin of cardiac fibroblasts and the role of periostin. Circulation Research, 105(10), 934–947. doi:10.1161/CIRCRESAHA.109.201400.
Gittenberger-de Groot, A. C. V. P. M., Mentink, M. M. T., Gourdie, R. G., & Poelmann, R. E. (1998). Epicardium-derived cells contribute a novel population to the myocardial wall and the atrioventricular cushions. Circulation Research, 82, 1043–1052.
Kolditz, D. P., Wijffels, M. C., Blom, N. A., van der Laarse, A., Hahurij, N. D., Lie-Venema, H., et al. (2008). Epicardium-derived cells in development of annulus fibrosis and persistence of accessory pathways. Circulation, 117(12), 1508–1517. doi:10.1161/CIRCULATIONAHA.107.726315.
Mikawa, T., & Gourdie, R. G. (1996). Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Developmental Biology, 174(2), 221–232. doi:10.1006/dbio.1996.0068.
Perez-Pomares, J. M., Carmona, R., Gonzalez-Iriarte, M., Atencia, G., Wessels, A., & Munoz-Chapuli, R. (2002). Origin of coronary endothelial cells from epicardial mesothelium in avian embryos. International Journal of Developmental Biology, 46(8), 1005–1013.
Lie-Venema, H., van den Akker, N. M., Bax, N. A., Winter, E. M., Maas, S., Kekarainen, T., et al. (2007). Origin, fate, and function of epicardium-derived cells (EPDCs) in normal and abnormal cardiac development. Scientific World Journal, 7, 1777–1798. doi:10.1100/tsw.2007.294.
Wessels, A., van den Hoff, M. J., Adamo, R. F., Phelps, A. L., Lockhart, M. M., Sauls, K., et al. Epicardially derived fibroblasts preferentially contribute to the parietal leaflets of the atrioventricular valves in the murine heart. Developmental Biology, 366(2), 111–124. doi:10.1016/j.ydbio.2012.04.020
Norris, R. A., Borg, T. K., Butcher, J. T., Baudino, T. A., Banerjee, I., & Markwald, R. R. (2008). Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin. Annals of the New York Academy of Sciences, 1123, 30–40. doi:10.1196/annals.1420.005.
Souders, C. A., Bowers, S. L., & Baudino, T. A. (2009). Cardiac fibroblast: the renaissance cell. Circulation Research, 105(12), 1164–1176. doi:10.1161/CIRCRESAHA.109.209809.
Zeisberg, E. M., Kalluri, R. Origins of cardiac fibroblasts. Circulation Research, 107(11), 1304–1312. doi:10.1161/CIRCRESAHA.110.231910
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13(8), 952–961. doi:10.1038/nm1613.
Visconti, R. P., & Markwald, R. R. (2006). Recruitment of new cells into the postnatal heart: potential modification of phenotype by periostin. Annals of the New York Academy of Sciences, 1080, 19–33. doi:10.1196/annals.1380.003.
Ebihara, Y., Masuya, M., Larue, A. C., Fleming, P. A., Visconti, R. P., Minamiguchi, H., et al. (2006). Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Experimental Hematology, 34(2), 219–229. doi:10.1016/j.exphem.2005.10.008.
Visconti, R. P., Ebihara, Y., LaRue, A. C., Fleming, P. A., McQuinn, T. C., Masuya, M., et al. (2006). An in vivo analysis of hematopoietic stem cell potential: hematopoietic origin of cardiac valve interstitial cells. Circulation Research, 98(5), 690–696. doi:10.1161/01.RES.0000207384.81818.d4.
van Amerongen, M. J., Bou-Gharios, G., Popa, E., van Ark, J., Petersen, A. H., van Dam, G. M., et al. (2008). Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. The Journal of Pathology, 214(3), 377–386. doi:10.1002/path.2281.
Endo, J., Sano, M., Fujita, J., Hayashida, K., Yuasa, S., Aoyama, N., et al. (2007). Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation, 116(10), 1176–1184. doi:10.1161/CIRCULATIONAHA.106.650903.
Haudek, S. B., Xia, Y., Huebener, P., Lee, J. M., Carlson, S., Crawford, J. R., et al. (2006). Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proceedings of the National Academy of Sciences of the United States of America, 103(48), 18284–18289. doi:10.1073/pnas.0608799103.
Diaz-Flores, L., Gutierrez, R., Madrid, J. F., Varela, H., Valladares, F., Acosta, E., et al. (2009). Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histology and Histopathology, 24(7), 909–969.
Krenning, G., Zeisberg, E. M., & Kalluri, R. The origin of fibroblasts and mechanism of cardiac fibrosis. Journal of Cellular Physiology, 225(3), 631–637. doi:10.1002/jcp.22322
Baudino, T. A., Carver, W., Giles, W., & Borg, T. K. (2006). Cardiac fibroblasts: friend or foe? American Journal of Physiology Heart and Circulatory Physiology, 291(3), H1015–H1026. doi:10.1152/ajpheart.00023.2006.
Snider, P., Hinton, R. B., Moreno-Rodriguez, R. A., Wang, J., Rogers, R., Lindsley, A., et al. (2008). Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart. Circulation Research, 102(7), 752–760. doi:10.1161/CIRCRESAHA.107.159517.
Kakkar, R., & Lee, R. T. Intramyocardial fibroblast myocyte communication. Circulation Research, 106(1), 47–57. doi:10.1161/CIRCRESAHA.109.207456
Takeda, N., & Manabe I. Cellular interplay between cardiomyocytes and nonmyocytes in cardiac remodeling. International Journal of Inflammation, 2011:535241. doi:10.4061/2011/535241
Ieda, M., Tsuchihashi, T., Ivey, K. N., Ross, R. S., Hong, T. T., Shaw, R. M., et al. (2009). Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Developmental Cell, 16(2), 233–244. doi:10.1016/j.devcel.2008.12.007.
Noseda, M., & Schneider, M. D. (2009). Fibroblasts inform the heart: control of cardiomyocyte cycling and size by age-dependent paracrine signals. Developmental Cell, 16(2), 161–162. doi:10.1016/j.devcel.2009.01.020.
Gaudesius, G., Miragoli, M., Thomas, S. P., & Rohr, S. (2003). Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circulation Research, 93(5), 421–428. doi:10.1161/01.RES.0000089258.40661.0C.
Vasquez, C., Mohandas, P., Louie, K. L., Benamer, N., Bapat, A. C., & Morley, G. E. Enhanced fibroblast–myocyte interactions in response to cardiac injury. Circulation Research, 107(8), 1011–1020. doi:10.1161/CIRCRESAHA.110.227421
Zhang, Y., Kanter, E. M., & Yamada, K. A. Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication. Cardiovascular Pathology, 19(6), e233–e240. doi:10.1016/j.carpath.2009.12.002
Miragoli, M., Gaudesius, G., & Rohr, S. (2006). Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circulation Research, 98(6), 801–810. doi:10.1161/01.RES.0000214537.44195.a3.
Spach, M. S., & Boineau, J. P. (1997). Microfibrosis produces electrical load variations due to loss of side-to-side cell connections: a major mechanism of structural heart disease arrhythmias. Pacing and Clinical Electrophysiology, 20(2 Pt 2), 397–413.
Ottaviano, F. G., & Yee, K. O. Communication signals between cardiac fibroblasts and cardiac myocytes. Journal of Cardiovascular Pharmacology, 57(5), 513–521. doi:10.1097/FJC.0b013e31821209ee
Kalluri, R., & Zeisberg, M. (2006). Fibroblasts in cancer. Nature Reviews Cancer, 6(5), 392–401. doi:10.1038/nrc1877.
Chang, H. Y., Chi, J. T., Dudoit, S., Bondre, C., van de Rijn, M., Botstein, D., et al. (2002). Diversity, topographic differentiation, and positional memory in human fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 99(20), 12877–12882. doi:10.1073/pnas.162488599.
Weber, K. T. (1997). Monitoring tissue repair and fibrosis from a distance. Circulation, 96(8), 2488–2492.
Takeda, N., Manabe, I., Uchino, Y., Eguchi, K., Matsumoto, S., Nishimura, S., et al. (2010). Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. Journal of Clinical Investigation, 120(1), 254–265. doi:10.1172/JCI40295
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature, doi:10.1038/nature11044
Lindsley, A., Snider, P., Zhou, H., Rogers, R., Wang, J., Olaopa, M., et al. (2007). Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. Developmental Biology, 307(2), 340–355. doi:10.1016/j.ydbio.2007.04.041.
Kruzynska-Frejtag, A., Machnicki, M., Rogers, R., Markwald, R. R., & Conway, S. J. (2001). Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation. Mechanisms of Development, 103(1–2), 183–188.
Lie-Venema, H., Gittenberger-de Groot, A. C., van Empel, L. J., Boot, M. J., Kerkdijk, H., de Kant, E., et al. (2003). Ets-1 and Ets-2 transcription factors are essential for normal coronary and myocardial development in chicken embryos. Circulation Research, 92(7), 749–756. doi:10.1161/01.RES.0000066662.70010.DB.
Smith, C. L., Baek, S. T., Sung, C. Y., & Tallquist, M. D. Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circulation Research, 108(12), e15–e26. doi:10.1161/CIRCRESAHA.110.235531
Vega-Hernandez, M., Kovacs, A., De Langhe, S., & Ornitz, D. M. FGF10/FGFR2b signaling is essential for cardiac fibroblast development and growth of the myocardium. Development, 138(15), 3331–3340. doi:10.1242/dev.064410
Horio, T., Maki, T., Kishimoto, I., Tokudome, T., Okumura, H., Yoshihara, F., et al. (2005). Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts. Regulatory Peptides, 124(1–3), 65–72. doi:10.1016/j.regpep.2004.06.029.
Borg, T. K., Ranson, W. F., Moslehy, F. A., & Caulfield, J. B. (1981). Structural basis of ventricular stiffness. Laboratory Investigation, 44(1), 49–54.
Borg, T. K., Rubin, K., Lundgren, E., Borg, K., & Obrink, B. (1984). Recognition of extracellular matrix components by neonatal and adult cardiac myocytes. Developmental Biology, 104(1), 86–96.
Soonpaa, M. H., Kim, K. K., Pajak, L., Franklin, M., & Field, L. J. (1996). Cardiomyocyte DNA synthesis and binucleation during murine development. American Journal of Physiology, 271(5 Pt 2), H2183–H2189.
Porrello, E. R., Mahmoud, A. I., Simpson, E., Hill, J. A., Richardson, J. A., Olson, E. N., et al. Transient regenerative potential of the neonatal mouse heart. Science, 331(6020), 1078–1080. doi:10.1126/science.1200708
Ieda, M., Fu, J. D., Delgado-Olguin, P., Vedantham, V., Hayashi, Y., Bruneau, B. G., et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell, 142(3), 375–386. doi:10.1016/j.cell.2010.07.002
Jayawardena, T. M., Egemnazarov, B., Finch, E. A., Zhang, L., Payne, J. A., Pandya, K., et al. MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes. Circulation Research, doi:10.1161/CIRCRESAHA.112.269035
Kawaguchi, M., Takahashi, M., Hata, T., Kashima, Y., Usui, F., Morimoto, H., et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation, 123(6), 594–604. doi:10.1161/CIRCULATIONAHA.110.982777
Goldsmith, E. C., Hoffman, A., Morales, M. O., Potts, J. D., Price, R. L., McFadden, A., et al. (2004). Organization of fibroblasts in the heart. Developmental Dynamics, 230(4), 787–794. doi:10.1002/dvdy.20095.
Matsusaka, T., Katori, H., Inagami, T., Fogo, A., & Ichikawa, I. (1999). Communication between myocytes and fibroblasts in cardiac remodeling in angiotensin chimeric mice. The Journal of Clinical Investigation, 103(10), 1451–1458. doi:10.1172/JCI5056.
Molkentin, J. D., Lu, J. R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., et al. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell, 93(2), 215–228.
Litchenberg, W. H., Norman, L. W., Holwell, A. K., Martin, K. L., Hewett, K. W., & Gourdie, R. G. (2000). The rate and anisotropy of impulse propagation in the postnatal terminal crest are correlated with remodeling of Cx43 gap junction pattern. Cardiovascular Research, 45(2), 379–387.
Zhang, Y., Kanter, E. M., Laing, J. G., Aprhys, C., Johns, D. C., Kardami, E., et al. (2008). Connexin43 expression levels influence intercellular coupling and cell proliferation of native murine cardiac fibroblasts. Cell Communication & Adhesion, 15(3), 289–303. doi:10.1080/15419060802198736.
Camelliti, P., Green, C. R., & Kohl, P. (2006). Structural and functional coupling of cardiac myocytes and fibroblasts. Advances in Cardiology, 42, 132–149. doi:10.1159/000092566.
Roell, W., Lewalter, T., Sasse, P., Tallini, Y. N., Choi, B. R., Breitbach, M., et al. (2007). Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature, 450(7171), 819–824. doi:10.1038/nature06321.
Bowers, S. L., Borg, T. K., & Baudino, T. A. The dynamics of fibroblast–myocyte–capillary interactions in the heart. Annals of the New York Academy of Sciences, 1188, 143–152. doi:10.1111/j.1749-6632.2009.05094.x
Conway, S. J., Doetschman, T., & Azhar, M. (2011). The inter-relationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. ScientificWorldJournal, 11, 1509–1524. doi:10.1100/tsw.2011.132.
Doetschman, T., Barnett, J. V., Runyan, R. B., Camenisch, T. D., Heimark, R. L., Granzier, H. L., et al. (2012). Transforming growth factor beta signaling in adult cardiovascular diseases and repair. Cell and Tissue Research, 347(1), 203–223. doi:10.1007/s00441-011-1241-3.
Katsuragi, N., Morishita, R., Nakamura, N., Ochiai, T., Taniyama, Y., Hasegawa, Y., et al. (2004). Periostin as a novel factor responsible for ventricular dilation. Circulation, 110(13), 1806–1813. doi:10.1161/01.CIR.0000142607.33398.54.
Wang, D., Oparil, S., Feng, J. A., Li, P., Perry, G., Chen, L. B., et al. (2003). Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension, 42(1), 88–95. doi:10.1161/01.HYP.0000074905.22908.A6.
Kudo, A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cellular and Molecular Life Sciences, 68(19), 3201–3207. doi:10.1007/s00018-011-0784-5
Stanton, L. W., Garrard, L. J., Damm, D., Garrick, B. L., Lam, A., Kapoun, A. M., et al. (2000). Altered patterns of gene expression in response to myocardial infarction. Circulation Research, 86(9), 939–945.
Conway, S. J., & Molkentin, J. D. (2008). Periostin as a heterofunctional regulator of cardiac development and disease. Current Genomics, 9(8), 548–555. doi:10.2174/138920208786847917.
Norris, R. A., Moreno-Rodriguez, R., Hoffman, S., & Markwald, R. R. (2009). The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology. Journal of Cell Communication and Signaling, 3(3–4), 275–286. doi:10.1007/s12079-009-0063-5.
Bao, S., Ouyang, G., Bai, X., Huang, Z., Ma, C., Liu, M., et al. (2004). Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway. Cancer Cell, 5(4), 329–339.
Gillan, L., Matei, D., Fishman, D. A., Gerbin, C. S., Karlan, B. Y., & Chang, D. D. (2002). Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility. Cancer Research, 62(18), 5358–5364.
Kim, C. J., Yoshioka, N., Tambe, Y., Kushima, R., Okada, Y., & Inoue, H. (2005). Periostin is down-regulated in high grade human bladder cancers and suppresses in vitro cell invasiveness and in vivo metastasis of cancer cells. International Journal of Cancer, 117(1), 51–58. doi:10.1002/ijc.21120.
Orlic, D., Kajstura, J., Chimenti, S., Bodine, D. M., Leri, A., & Anversa, P. (2001). Transplanted adult bone marrow cells repair myocardial infarcts in mice. Annals of the New York Academy of Sciences, 938, 221–229. discussion 229–230.
Orlic, D., Kajstura, J., Chimenti, S., Jakoniuk, I., Anderson, S. M., Li, B., et al. (2001). Bone marrow cells regenerate infarcted myocardium. Nature, 410(6829), 701–705. doi:10.1038/35070587.
Jackson, K. A., Majka, S. M., Wang, H., Pocius, J., Hartley, C. J., Majesky, M. W., et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. The Journal of Clinical Investigation, 107(11), 1395–1402. doi:10.1172/JCI12150.
Kocher, A. A., Schuster, M. D., Szabolcs, M. J., Takuma, S., Burkhoff, D., Wang, J., et al. (2001). Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nature Medicine, 7(4), 430–436. doi:10.1038/86498.
Yeh, E. T., Zhang, S., Wu, H. D., Korbling, M., Willerson, J. T., & Estrov, Z. (2003). Transdifferentiation of human peripheral blood CD34+-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation, 108(17), 2070–2073. doi:10.1161/01.CIR.0000099501.52718.70.
Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418(6893), 41–49. doi:10.1038/nature00870.
Shimazaki, M., Nakamura, K., Kii, I., Kashima, T., Amizuka, N., Li, M., et al. (2008). Periostin is essential for cardiac healing after acute myocardial infarction. The Journal of Experimental Medicine, 205(2), 295–303. doi:10.1084/jem.20071297.
Fan, Y. H., Dong, H., Pan, Q., Cao, Y. J., Li, H., & Wang, H. C. Notch signaling may negatively regulate neonatal rat cardiac fibroblast–myofibroblast transformation. Physiological Research, 60(5), 739–748.
Baum, J., & Duffy, H. S. Fibroblasts and myofibroblasts: what are we talking about? Journal of Cardiovascular Pharmacology, 57(4), 376–379. doi:10.1097/FJC.0b013e3182116e39
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000). Induction of cardiac fibrosis by transforming growth factor-beta(1). Molecular Genetics and Metabolism, 71(1–2), 418–435. doi:10.1006/mgme.2000.3032.
Wight, T. N., & Potter-Perigo, S. The extracellular matrix: an active or passive player in fibrosis? American Journal of Physiology Gastrointestinal and Liver Physiology, 301(6), G950–G955. doi:10.1152/ajpgi.00132.2011
Meyer, A., Wang, W., Qu, J., Croft, L., Degen, J. L., Coller, B. S., et al. (2012). Platelet TGF-beta1 contributions to plasma TGF-beta1, cardiac fibrosis, and systolic dysfunction in a mouse model of pressure overload. Blood, 119(4), 1064–1074. doi:10.1182/blood-2011-09-377648.
Bai, D., Gao, Q., Li, C., Ge, L., Gao, Y., & Wang, H. A conserved TGFbeta1/HuR feedback circuit regulates the fibrogenic response in fibroblasts. Cellular Signalling, 24(7), 1426–1432. doi:10.1016/j.cellsig.2012.03.003
Azhar, M., Yin, M., Bommireddy, R., Duffy, J. J., Yang, J., Pawlowski, S. A., et al. (2009). Generation of mice with a conditional allele for transforming growth factor beta 1 gene. Genesis, 47(6), 423–431. doi:10.1002/dvg.20516.
Doetschman, T., Georgieva, T., Li, H., Reed, T. D., Grisham, C., Friel, J., et al. Generation of mice with a conditional allele for the transforming growth factor beta3 gene. Genesis, 50(1), 59–66. doi:10.1002/dvg.20789
Pelton, R. W., Saxena, B., Jones, M., Moses, H. L., & Gold, L. I. (1991). Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. The Journal of Cell Biology, 115(4), 1091–1105.
Acknowledgments
We thank the members of the Conway lab, Dr. Mohamad Azhar, and the reviewers for their insightful comments. These studies were supported, in part, by Riley Children’s Foundation, and Indiana University Department of Pediatrics (Neonatal-Perinatal Medicine) and National Institute of Health [HL60714] to SJC.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lajiness, J.D., Conway, S.J. The Dynamic Role of Cardiac Fibroblasts in Development and Disease. J. of Cardiovasc. Trans. Res. 5, 739–748 (2012). https://doi.org/10.1007/s12265-012-9394-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9394-3